N-[(4-cyclohexa-1,5-dien-1-yloxyphenyl)-phenylmethyl]-2-oxo-6-(trifluoromethyl)-1H-pyridine-3-carboxamide
C26H21F3N2O3 — CID 155571854
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(4-cyclohexa-1,5-dien-1-yloxyphenyl)-phenylmethyl]-2-oxo-6-(trifluoromethyl)-1H-pyridine-3-carboxamide
N-[(4-cyclohexa-1,5-dien-1-yloxyphenyl)-phenylmethyl]-2-oxo-6-(trifluoromethyl)-1H-pyridine-3-carboxamide (PubChem CID 155571854) has the molecular formula C26H21F3N2O3 and a molecular weight of 466.46 g/mol. Its IUPAC name is N-[(4-cyclohexa-1,5-dien-1-yloxyphenyl)-phenylmethyl]-2-oxo-6-(trifluoromethyl)-1H-pyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[(4-cyclohexa-1,5-dien-1-yloxyphenyl)-phenylmethyl]-2-oxo-6-(trifluoromethyl)-1H-pyridine-3-carboxamide |
|---|---|
| PubChem CID | 155571854 |
| Molecular Formula | C26H21F3N2O3 |
| Molecular Weight | 466.46 g/mol |
| Exact Mass | 466.15 |
| IUPAC Name | N-[(4-cyclohexa-1,5-dien-1-yloxyphenyl)-phenylmethyl]-2-oxo-6-(trifluoromethyl)-1H-pyridine-3-carboxamide |
| SMILES | O=C(NC(c1ccccc1)c1ccc(OC2=CCCC=C2)cc1)c1ccc(C(F)(F)F)[nH]c1=O |
| InChI | InChI=1S/C26H21F3N2O3/c27-26(28,29)22-16-15-21(24(32)30-22)25(33)31-23(17-7-3-1-4-8-17)18-11-13-20(14-12-18)34-19-9-5-2-6-10-19/h1,3-5,7-16,23H,2,6H2,(H,30,32)(H,31,33) |
| InChIKey | MACKQFKSLVGMDZ-UHFFFAOYSA-N |
| XLogP | 5.53 |
| TPSA | 71.19 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 466.46 |
| LogP ≤ 5 | 5.53 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155571854 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.